Literature DB >> 33446823

In vivo multimodal optical imaging of dermoscopic equivocal melanocytic skin lesions.

V Elagin1, E Gubarkova2, O Garanina2, D Davydova3, N Orlinskaya2, L Matveev4, I Klemenova2, I Shlivko2, M Shirmanova2, E Zagaynova2,5.   

Abstract

There is a wide range of equivocal melanocytic lesions that can be clinically and dermoscopically indistinguishable from early melanoma. In the present work, we assessed the possibilities of combined using of multiphoton microscopy (MPM) and optical coherence angiography (OCA) for differential diagnosis of the equivocal melanocytic lesions. Clinical and dermoscopic examinations of 60 melanocytic lesions revealed 10 benign lesions and 32 melanomas, while 18 lesions remained difficult to diagnose. Histopathological analysis of these lesions revealed 4 intradermal, 3 compound and 3 junctional nevi in the "benign" group, 7 superficial spreading, 14 lentigo maligna and 11 nodular melanomas in the "melanoma" group and 2 lentigo simplex, 4 dysplastic nevi, 6 melanomas in situ, 4 invasive lentigo melanomas and 2 invasive superficial spreading melanomas in the "equivocal" group. On the basis of MPM, a multiphoton microscopy score (MPMS) has been developed for quantitative assessment of melanoma features at the cellular level, that showed lower score for benign lesions compare with malignant ones. OCA revealed that the invasive melanoma has a higher vessel density and thicker blood vessels than melanoma in situ and benign lesions. Discriminant functions analysis of MPM and OCA data allowed to differentiate correctly between all equivocal melanocytic lesions. Therefore, we demonstrate, for the first time, that a combined use of MPM and OCA has the potential to improve early diagnosis of melanoma.

Entities:  

Year:  2021        PMID: 33446823      PMCID: PMC7809210          DOI: 10.1038/s41598-020-80744-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

1.  Spectral fluorescence lifetime detection and selective melanin imaging by multiphoton laser tomography for melanoma diagnosis.

Authors:  Enrico Dimitrow; Iris Riemann; Alexander Ehlers; Martin Johannes Koehler; Johannes Norgauer; Peter Elsner; Karsten König; Martin Kaatz
Journal:  Exp Dermatol       Date:  2009-02-25       Impact factor: 3.960

2.  Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.

Authors:  Mohammed Kashani-Sabet; Richard W Sagebiel; Carlos M M Ferreira; Mehdi Nosrati; James R Miller
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

3.  Langerhans cells and melanocytes share similar morphologic features under in vivo reflectance confocal microscopy: a challenge for melanoma diagnosis.

Authors:  Pantea Hashemi; Melissa P Pulitzer; Alon Scope; Ivanka Kovalyshyn; Allan C Halpern; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2011-07-28       Impact factor: 11.527

4.  The problem of false-positive diagnosis in melanoma screening: the impact of dermoscopy.

Authors:  Paolo Carli; Francesca Mannone; Vincenzo De Giorgi; Paolo Nardini; Alessandra Chiarugi; Benvenuto Giannotti
Journal:  Melanoma Res       Date:  2003-04       Impact factor: 3.599

5.  Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study.

Authors:  I Tromme; L Sacré; F Hammouch; C Legrand; L Marot; P Vereecken; I Theate; P van Eeckhout; P Richez; J F Baurain; L Thomas; N Speybroeck
Journal:  Br J Dermatol       Date:  2012-08-20       Impact factor: 9.302

6.  Accuracy of Skin Cancer Diagnosis by Physician Assistants Compared With Dermatologists in a Large Health Care System.

Authors:  Alyce M Anderson; Martha Matsumoto; Melissa I Saul; Aaron M Secrest; Laura K Ferris
Journal:  JAMA Dermatol       Date:  2018-05-01       Impact factor: 10.282

7.  Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics.

Authors:  Stefania Seidenari; Federica Arginelli; Christopher Dunsby; Paul M W French; Karsten König; Cristina Magnoni; Clifford Talbot; Giovanni Ponti
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

8.  Photodynamic therapy monitoring with optical coherence angiography.

Authors:  M A Sirotkina; L A Matveev; M V Shirmanova; V Y Zaitsev; N L Buyanova; V V Elagin; G V Gelikonov; S S Kuznetsov; E B Kiseleva; A A Moiseev; S V Gamayunov; E V Zagaynova; F I Feldchtein; A Vitkin; N D Gladkova
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

9.  Accurate early prediction of tumour response to PDT using optical coherence angiography.

Authors:  M A Sirotkina; A A Moiseev; L A Matveev; V Y Zaitsev; V V Elagin; S S Kuznetsov; G V Gelikonov; S Y Ksenofontov; E V Zagaynova; F I Feldchtein; N D Gladkova; A Vitkin
Journal:  Sci Rep       Date:  2019-04-24       Impact factor: 4.379

10.  Quantifying optical microangiography images obtained from a spectral domain optical coherence tomography system.

Authors:  Roberto Reif; Jia Qin; Lin An; Zhongwei Zhi; Suzan Dziennis; Ruikang Wang
Journal:  Int J Biomed Imaging       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.